The Company officially changed its name to Nordion Inc. on November 1, 2010. Prior to November the Company's name was MDS Inc.
Nordion Executive Management Team
Steve M. West
Chief Executive Officer
Steve West was appointed Chief Executive Officer of Nordion Inc. (formerly MDS Inc.) in January 2010. Steve, who in September 2009 was appointed Chief Operating Officer, has served as President of Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President, DiverseyLever Canada. His background includes various CEO assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field. Steve has a degree in Genetics from London University (UK) and completed postgraduate research in Biotechnology.
Chief Financial Officer
Peter Dans joined Nordion (formerly MDS Inc.) in August 2007 as Vice-President, Financial Planning & Analysis. He was appointed CFO of Nordion in February 2010. Before joining Nordion, Peter held global finance leadership roles at Nortel in North America, Singapore and the Philippines where he acquired significant external reporting and financial operating experience. Peter also held the CFO position at LG-Nortel in South Korea. Peter earned a B.Sc. in Engineering Physics from Queens University, an MBA from York University – Schulich School of Business, and holds a CMA and Professional Engineering designations.
Senior Vice-President, Corporate Services
Christopher Ashwood joined Nordion in 2008 with more than 23 years of experience in Human Resources, Business Development and Information Technology. He joined Nordion from Nortel, where he held a number of key leadership positions including Vice-President Product Development Solutions, Vice-President Global Business Processes and Director Corporate Services. Chris holds a MBA from the University of Ottawa and a BA from Carleton University.
Senior Vice-President, General Counsel & Corporate Secretary
Grant Gardiner joined Nordion in 2013 with extensive experience leading publicly-traded companies through complex legal, governance and compliance landscapes. He is a well-respected practitioner in the areas of mergers and acquisitions, corporate governance, commercial transactions, as well as securities and anti-corruption law. Grant has previously served as Vice-President, Associate General Counsel, as well as Corporate Secretary, for BlackBerry (RIM), and has held leadership roles at other global, publicly-traded companies such as Cognos Inc. (now IBM) and JDS Uniphase. He holds a Bachelor of Business Administration from the University of Prince Edward Island (1988), an L.L.B. from Osgoode Hall Law School (1991) and was admitted to the Ontario Bar in 1993.
Chief Operating Officer, Specialty Isotopes & General Manager, Sterilization Technologies
Since joining Nordion in 2000, Scott McIntosh has held a variety of VP positions in Operations and Marketing in each of Nordion's business areas. Prior to joining Nordion, Scott was at Pepsico for 10 years where he held a number of senior Operations and Engineering roles. Scott holds a BSc (Engineering) and a MBA from Queen's University.
Vice-President, Public and Government Relations
Tamra Benjamin joined Nordion in 2006 and was named Vice-President, Communications in 2009. Prior to joining Nordion, Tamra worked for more than 20 years in the high-tech market with several start-ups and for many years with Nortel. Tamra has extensive experience in all areas of communication, including public relations and crisis management. She holds a MBA from the University of McGill and an undergraduate degree from the University of Saskatchewan.
General Manager, Medical Isotopes
Tom Burnett joined Nordion in 2006 as the Global Marketing Director for Medical Isotopes. Before assuming his current role in September 2012, Tom held the position of Vice President, Global Sales. Prior to joining Nordion, Tom was at Thermo Fisher Scientific for 8 years where he held a number of senior positions in Business Development, Marketing and Sales. Earlier in his career, Tom was a Management Consultant in Ernst & Young’s Life Science Practice in Toronto working with Biotech and Pharmaceutical companies as well as government and public sector health care institutions. Tom earned a BSc in Chemistry from the University of Western Ontario, an MSc in Organometallic Chemistry from Queen’s University and an MBA from the Richard Ivey School of Business at the University of Western Ontario.